InternationalUSRemember you can easily switch between MIP US and MIP International at any time

Twenty cases that will change the way you work


Managing IP's cases of the year for 2012 includes the annual top 10, plus 10 smaller rulings you might have missed. By Emma Barraclough, Simon Crompton, Peter Leung, Paul Madill, Eileen McDermott, James Nurton and Alli Pyrah

This has not been a year for blockbuster cases. Even though the volume of litigation remains high, neither Europe nor Asia has thrown up many surprising results. And though the United States has given us Louboutin's red-soled shoes and the first jury trial in Apple v Samsung, both cases covered issues that had been raised the year before.

Rather, 2012 was characterised by a series of cases with important but...


Please log in to read the rest of this article.

New to Managing Intellectual Property? Take advantage of one week’s FREE access and become a Managing IP member today. It’s free to join and the benefits start straight away.

Already registered?

Please make sure you log in to read the rest of the article.

Log in

Join us now

Gain 7 days FREE access when you register now.

Join here

profile

Managing IP

ManagingIP

ManagingIP profile

RT @mdloney: My weekly IP roundup, feat Happy Birthday, Burberry, banking patents, Dish, Authors Guild https://t.co/rFBv4QbIPJ' target='blank'>https://t.co/rFBv4QbIPJ https://t.co

Feb 12 2016 11:19 ·  reply ·  retweet ·  favourite
ManagingIP profile

Some useful pointers here! #trademarks https://t.co/zxz24VNoYc

Feb 12 2016 05:52 ·  reply ·  retweet ·  favourite
ManagingIP profile

ICYMI: @USChamber @globalIPcenter releases annual IP index https://t.co/5e1UkGRLM4 https://t.co/1Uan9ZjOIe

Feb 12 2016 05:51 ·  reply ·  retweet ·  favourite
More from the Managing IP blog


February 2016

A new era for EU trade marks

Are you ready for the fundamental changes coming to trade mark law and practice in Europe? Over the next four pages, we provide pointers for steps you need to consider – and when. By James Nurton



Most read articles

Supplements